Open AccessExpert consensus on maintenance treatment for metastatic colorectal cancer in China
Author(s) -
Xu RuiHua,
Shen Lin,
Li Jin,
Xu JianMing,
Bi Feng,
Ba Yi,
Bai Li,
Shu YongQian,
Liu TianShu,
Li YuHong,
Bai ChunMei,
Yuan XiangLin,
Zhang Jun,
Chen Gong,
Zhou AiPing,
Yuan Ying,
Wang XiJing,
Qian XiaoPing,
Deng YanHong
Publication year - 2016
Publication title -
cancer communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 53
ISSN - 2523-3548
DOI - 10.1186/s40880-015-0067-x
Subject(s) - colorectal cancer , medicine , maintenance therapy , oncology , quality of life (healthcare) , intensive care medicine , clinical trial , china , overall survival , cancer , chemotherapy , nursing , political science , law
The impact of maintenance therapy on progression‐free survival and overall survival as well as quality of life of Chinese patients with metastatic colorectal cancer has long been under discussion. Recently, some phase III clinical trials have revealed that maintenance therapy can significantly prolong the progression‐free survival while maintain an acceptable safety profile. Based on this evidence and common treatment practice in China, we now generated one Expert Consensus on Maintenance Treatment for Metastatic Colorectal Cancer in China to further specify the necessity of maintenance therapy, suitable candidates for such treatment, and appropriate regimens.